These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6455095)

  • 21. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
    NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
    Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative double blind study of topical clindamycine phosphate, oral tetracycline chlorhydrate and a placebo in the treatment of moderate to severe acne vulgaris].
    Guertin-Larochelle S; Raymond GP; Gratton D; Collins JP; Gaudreau P
    Union Med Can; 1982 Jun; 111(6):559-62. PubMed ID: 6214069
    [No Abstract]   [Full Text] [Related]  

  • 24. [Topical treatment of acne vulgaris with clindamycin].
    Mobacken H; Hersle K
    Lakartidningen; 1985 Oct; 82(42):3595-7. PubMed ID: 2932616
    [No Abstract]   [Full Text] [Related]  

  • 25. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
    Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
    Eichenfield LF; Wortzman M
    Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
    Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
    Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
    Stoughton RB; Cornell RC; Gange RW; Walter JF
    Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
    Thiboutot D; Zaenglein A; Weiss J; Webster G; Calvarese B; Chen D
    J Am Acad Dermatol; 2008 Nov; 59(5):792-800. PubMed ID: 18805603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
    Touitou E; Godin B; Shumilov M; Bishouty N; Ainbinder D; Shouval R; Ingber A; Leibovici V
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):629-31. PubMed ID: 18410627
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acne vulgaris with clindamycin phosphate in dermatologic practice].
    Schneider WD
    Z Hautkr; 1985 Oct; 60(20):1599-608. PubMed ID: 2932864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical clindamycin in acne vulgaris. Safety and stability.
    Algra RJ; Rosen T; Waisman M
    Arch Dermatol; 1977 Oct; 113(10):1390-1. PubMed ID: 143910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical tetracycline hydrochloride vs. topical clindamycin phosphate in the treatment of acne: a comparative study.
    Padilla RS; McCabe JM; Becker LE
    Int J Dermatol; 1981; 20(6):445-8. PubMed ID: 6455388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.